Source: Annual Congress 2002 - Prevalence and costs of COPD
Disease area: Airway diseases

Abstract

There is no published information on the prevalence of Chronic Obstructive Pulmonary Disease in Greece. The aim of this study was to determine recent prevalence and trends of COPD amongst adults in the Greece. The study involved 635 randomly identified adults (369 males, 266 females) aged over 35 yrs. smokers at least 100 cigarettes per life-time in a population-based, multi-regional cross-sectional descriptive design. The selected individuals were reflected the urban/rural population distribution in Greece, while within each study region, individuals were selected to reflect the age group and gender of the community setting. Twenty-five pulmonologists members of the COPD group of the Hellenic Thoracic Society performed the study. The diagnosis of COPD was defined according to ERS statement (Eur Respir J 1995; 8:1398-420) and classified as mild, moderate and severe. The overall prevalence was 6.9%. The gender-standardized COPD prevalence was 9.2 for males and 3.8% for females. The COPD prevalence by community setting was: Athens 7.6%, other urban 4.8%, semi-urban 5.2%, and rural 9.2%. In both men and women an increase of the COPD prevalence reflecting the increase of the age group was observed.

Rating:

Share or cite this content

Citations should be made in the following way:
N. M. Siafakas, (On Behalf of COPD Group) (Heraklion, Greece). Prevalence of chronic obstructive pulmonary disease (COPD) in Greece. Eur Respir J 2002; 20: Suppl. 38, 814

Member's Comments

No comment yet.

Related content which might interest you: Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Functional illiteracy amongst those with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal general practicioners Source: Eur Respir J 2007; 30: Suppl. 51, 129s Year: 2007 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan Source: Eur Respir J 2006; 28: Suppl. 50, 108s Year: 2006 Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006 Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Accelerated ageing and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 The evaluation of a helpline for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008